Business · 13/03/2023Updated: 10/17/2026 · 1 min read
FDA Issues Emergency Use Authorization for COVID-19 Treatment Drug KINERET
Summary
The US Food and Drug Administration (FDA) has granted emergency use authorization for the drug product KINERET (anakinra) to treat COVID-19, following a public health emergency declaration by the Secretary of Health and Human Services in March 2020.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →